Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Blog

Revvityブログ

発見から治療までのイノベーションを促進

Latest

Advancing therapeutic strategies for CSF1R-ALSP.

Assay Development Workflows October 17, 2025 - 5 min read
Read
Functional Genomic Screening

Arrayed or pooled library? Make the right first move in your CRISPR screen.

May 21, 2025 - 2 min read
Read
Functional Genomic Screening

Synthetic CRISPR sgRNA libraries enable scalable genome-wide activation screening.

April 16, 2025 - 4 min read
Read
Functional Genomic Screening

CRISPRa and CRISPRi: tracing the origins and exploring the future.

April 16, 2025 - 5 min read
Read
Functional Genomic Screening

Unlocking biological questions with functional genomics.

February 27, 2025 - 6 min read
Read
Functional Genomic Screening

Mastering screening: Validating and following up on hits from loss-of-function screens.

February 20, 2025 - 2 min read
Read
Pagination
  • First page « 最初
  • Previous page Previous
  • ページ 1
  • Current page 2
line

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.